Ocugen.com β Website Analysis
Comprehensive traffic, valuation, and technical report for ocugen.com
ocugen.com has a global rank of #980,621 with an estimated 8 daily visitors. Based on current traffic levels, the domain is valued at approximately $7,138.
The site runs on a .com (commercial) domain with servers located in United States, primary IP address 173.201.76.29, an active HTTPS configuration. Its homepage is titled βOcugen Inc. - Patient-Centric Biotechnologyβ.
ocugen.com was first registered on 2013-09-10 through GoDaddy.com, LLC.
Users commonly reach ocugen.com by searching for "ocugen stock", "ocugen", "ocugen stocktwits", "ocugen news", "ocugen share price".
People searching for these terms often visit ocugen.com:
ocugen stockocugenocugen stocktwitsocugen newsocugen share priceocugen stock forecastocugen hyderabadocugen malvern paocugen pipelineocugen price prediction| SSL Certificate | Secure |
| Security Score | 0% |
| Strict-Transport-Security | β |
| Content-Security-Policy | β |
| X-Content-Type-Options | β |
| X-Frame-Options | β |
| X-XSS-Protection | β |
Based on our analysis, ocugen.com implements HTTPS encryption and scores 0% on security headers. There is room for improvement in security configuration.
ocugen.com is missing 5 of 5 recommended security headers (Strict-Transport-Security, Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, X-XSS-Protection). This leaves visitors more exposed to browser-based attacks.
| Purchase/Sale Value | $7,138 |
| Daily Revenue | $5 |
| Monthly Revenue | $149 |
| Yearly Revenue | $1,785 |
| Daily Visitors | 8 |
All values are estimates based on publicly available traffic data.
ocugen.com ranks #980,621 globally. While outside the top 100k, the site maintains an active presence with regular visitors.
These are the websites closest to ocugen.com in global traffic ranking.
| Website | ocugen.com |
| Domain Age | 2013-09-10 19:05:13 |
| TLD | .com |
| Hosting Location | United States |
| Primary IP | 173.201.76.29 |
Hosted in the United States, ocugen.com benefits from low latency for North American visitors and proximity to major internet exchange points.
Active since 2013 (12 years), ocugen.com has a decade-plus track record β a sign of a stable, established web presence.
ocugen.com uses ocugen stock, ocugen, ocugen stocktwits, ocugen news, ocugen share price in its technology stack.
| Host | Type | IP | Nameserver |
|---|---|---|---|
| ocugen.com | A | 173.201.76.29 | ns58.domaincontrol.com. |
| ocugen.com | A | 97.74.108.29 | ns57.domaincontrol.com. |
Cache-Control
Connection
Content-Type
Date
Keep-Alive
Link
Server
Vary
X-Frame-Options
X-Powered-By
| Registrar | GoDaddy.com, LLC |
| Registered | 2013-09-10 19:05:13 |
| Status | Active |
Active since 2013 (12 years), ocugen.com has a decade-plus track record β a sign of a stable, established web presence.
Full WHOIS record βHow much is ocugen.com worth?
ocugen.com has an estimated value of $7,138 based on its traffic volume, global ranking, and projected advertising revenue.
How much traffic does ocugen.com get?
ocugen.com receives approximately 8 unique visitors per day. Its global traffic rank is #980,621.
Is ocugen.com safe to visit?
ocugen.com uses HTTPS encryption and has an active SSL certificate, which is a positive indicator of security. Always exercise caution when entering personal information on any website.
Where is ocugen.com hosted?
The servers for ocugen.com are located in United States.
Who owns ocugen.com?
Ownership details for ocugen.com can be found in the WHOIS section below. Many domain owners use privacy protection services to keep their registration details private.
How does ocugen.com rank compared to other .com websites?
With a global rank of #980,621, ocugen.com is a recognized .com domain.
| Domain | ocugen.com |
| TLD | .com |
| SSL | Secure |
| Server Location | United States |
| Global Rank | #980,621 |
| Registrar | GoDaddy.com, LLC |
| Domain Age | 2013-09-10 19:05:13 |
| Title | Ocugen Inc. - Patient-Centric Biotechnology |
| Description | Ocugen, develops novel solutions to medical challenges, to deliver new breakthroughs for people living with disease. |